Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 5.1 Opinion of Goodwin Procter LLP As to the Validity of the Securities Being Registered
- 23.1 Consent of Citrin Cooperman & Company LLP (with Respect to the Phoenix Biotech Acquisition Corp. Financial Statements)
- 23.2 Consent of Wolf & Company, P.C. (with Respect to CERO Therapeutics, Inc. Financial Statements)
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
Associated filings
CERO similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of CERo Therapeutics Holdings, Inc. of our report dated April 1, 2024, relating to the financial statements of CERo Therapeutics, Inc., appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the caption “Experts” in such Prospectus.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
April 10, 2024